Layas, G. et al. 2025. Impact of Bulky & Liposomal Secukinumab on Lymphocytes of Psoriatic Patients, to Determine the Improvement in Bioavailability of Secukinumab Nanolipo. American Journal of Life Science and Innovation. 4, 1 (Jun. 2025), 27–35. DOI:https://doi.org/10.54536/ajlsi.v4i1.3268.